Unknown

Dataset Information

0

Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer.


ABSTRACT: BACKGROUND:Serum cell-free DNA (cfDNA) holds promise as a non-invasive cancer biomarker. The objective of this study was to evaluate the association of cfDNA concentration with clinicopathologic variables of poor prognosis and overall survival among women with uterine cancer compared to benign cancer-free controls. METHODS:cfDNA was extracted from the serum of 91 women with multiple uterine cancer histologies and 22 post-menopausal controls without cancer. Low molecular weight (LMW) cfDNA was separated from contaminating genomic high molecular weight cfDNA using paramagnetic bead purification and its concentration was measured using fluorometric quantification. Clinicopathologic data was abstracted from the electronic medical record. The association between serum cfDNA concentration, clinicopathologic variables, and overall survival was assessed using linear regression modelling, Cox proportional hazards modelling, and the Kaplan-Meier method. RESULTS:Median total serum cfDNA concentration for the cohort was 69.2 ng/mL (IQR 37.4, 132.3) and median LMW cfDNA concentration was 23.8 ng/mL (IQR 14.9, 44.4). There were no significant differences in total serum cfDNA concentration with any clinicopathologic variables. However, LMW cfDNA concentration was significantly higher in serum of women with cancer (25.8 ng/mL IQR 16.0, 49.6) compared to benign controls (15.5 ng/mL IQR 9.3, 25.8 ng/mL) (p?

SUBMITTER: Gressel GM 

PROVIDER: S-EPMC7457235 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer.

Gressel Gregory M GM   Maggi Elaine C EC   Harmon Bryan E BE   Ye Kenny Q KQ   Kuo D Y S DYS   Dolan Siobhan M SM   Montagna Cristina C  

Journal of translational medicine 20200827 1


<h4>Background</h4>Serum cell-free DNA (cfDNA) holds promise as a non-invasive cancer biomarker. The objective of this study was to evaluate the association of cfDNA concentration with clinicopathologic variables of poor prognosis and overall survival among women with uterine cancer compared to benign cancer-free controls.<h4>Methods</h4>cfDNA was extracted from the serum of 91 women with multiple uterine cancer histologies and 22 post-menopausal controls without cancer. Low molecular weight (LM  ...[more]

Similar Datasets

| S-EPMC6753374 | biostudies-literature
| S-EPMC3991451 | biostudies-literature
| S-EPMC10060368 | biostudies-literature
| S-EPMC4228363 | biostudies-literature
| S-EPMC6472030 | biostudies-literature
| S-EPMC4548345 | biostudies-literature
| S-EPMC7593226 | biostudies-literature
| S-EPMC3739822 | biostudies-literature
| S-EPMC3616883 | biostudies-literature
| S-EPMC4058702 | biostudies-literature